These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 25650695)
61. Association of serum retinol-binding protein 4 with insulin resistance and metabolic parameters during olanzapine therapy. Faghihi T; Radfar M; Abdoli E; Amini H; Hemami MR; Larijani B Clin Endocrinol (Oxf); 2012 Feb; 76(2):207-11. PubMed ID: 21711373 [TBL] [Abstract][Full Text] [Related]
62. Induction or exacerbation of psoriasis in patients with Crohn's disease under treatment with anti-TNF antibodies. Barthel C; Biedermann L; Frei P; Vavricka SR; Kündig T; Fried M; Rogler G; Scharl M Digestion; 2014; 89(3):209-15. PubMed ID: 24853251 [TBL] [Abstract][Full Text] [Related]
63. Elevated serum retinol-binding protein 4 is associated with insulin resistance in older women. Suh JB; Kim SM; Cho GJ; Choi KM; Han JH; Taek Geun H Metabolism; 2010 Jan; 59(1):118-22. PubMed ID: 19766271 [TBL] [Abstract][Full Text] [Related]
64. Developing a Therapeutic Range of Adalimumab Serum Concentrations in Management of Psoriasis: A Step Toward Personalized Treatment. Menting SP; Coussens E; Pouw MF; van den Reek JM; Temmerman L; Boonen H; de Jong EM; Spuls PI; Lambert J JAMA Dermatol; 2015 Jun; 151(6):616-22. PubMed ID: 25807311 [TBL] [Abstract][Full Text] [Related]
65. Association of urinary RBP4 with insulin resistance, inflammation, and microalbuminuria. Park SE; Lee NS; Park JW; Rhee EJ; Lee WY; Oh KW; Park SW; Park CY; Youn BS Eur J Endocrinol; 2014 Oct; 171(4):443-9. PubMed ID: 24994759 [TBL] [Abstract][Full Text] [Related]
66. Clinical significance of serum retinol binding protein-4 levels in patients with systemic sclerosis. Toyama T; Asano Y; Takahashi T; Aozasa N; Akamata K; Noda S; Taniguchi T; Ichimura Y; Sumida H; Tamaki Z; Masui Y; Tada Y; Sugaya M; Sato S; Kadono T J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):337-44. PubMed ID: 22211766 [TBL] [Abstract][Full Text] [Related]
67. Anti-TNF agents for the treatment of psoriasis. Kircik LH; Del Rosso JQ J Drugs Dermatol; 2009 Jun; 8(6):546-59. PubMed ID: 19537380 [TBL] [Abstract][Full Text] [Related]
68. Macrophages are novel sites of expression and regulation of retinol binding protein-4 (RBP4). Broch M; Ramírez R; Auguet MT; Alcaide MJ; Aguilar C; Garcia-España A; Richart C Physiol Res; 2010; 59(2):299-303. PubMed ID: 19537932 [TBL] [Abstract][Full Text] [Related]
69. The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial. Al-Mutairi N; Nour T Expert Opin Biol Ther; 2014 Jun; 14(6):749-56. PubMed ID: 24661040 [TBL] [Abstract][Full Text] [Related]
70. Decreased retinol-binding protein 4 in the sera of patients with end-stage renal disease after kidney transplantation. Zhang WX; Zhou W; Zhang ZM; Zhang ZQ; He JF; Shi BY Genet Mol Res; 2014 Oct; 13(4):8126-34. PubMed ID: 25299197 [TBL] [Abstract][Full Text] [Related]
71. Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy. Chiricozzi A; Cannizzaro MV; Salandri GA; Marinari B; Pitocco R; Dattola A; Regine F; Saraceno R; Bianchi L; Chimenti S; Costanzo A J Eur Acad Dermatol Venereol; 2016 Nov; 30(11):e128-e129. PubMed ID: 26481299 [No Abstract] [Full Text] [Related]
72. TNF-alpha inhibition could reduce biomarkers of endothelial dysfunction in patients with moderate to severe psoriasis: A 52-week echo-Doppler based quasi-experimental study. Molina-Leyva A; Garrido-Pareja F; Ruiz-Carrascosa JC; Ruiz-Villaverde R Med Clin (Barc); 2018 Jun; 150(12):465-468. PubMed ID: 29089115 [TBL] [Abstract][Full Text] [Related]
73. Occurrence of a granulomatous mastitis and aseptic osteitis after anti-TNF therapy in a patient with pustular psoriasis. Garraud T; Barbarot S; Berthelot JM; Le Goff B Joint Bone Spine; 2016 Jan; 83(1):107-8. PubMed ID: 26054447 [No Abstract] [Full Text] [Related]
74. Skin advanced glycation end products as a diagnostic and monitoring tool among psoriatic patients: how the therapy helps reduce cardiovascular disease risk. Lanna C; Zangrilli A; Bavetta M; Diluvio L; Campione E; Bianchi L Int J Dermatol; 2022 May; 61(5):577-581. PubMed ID: 34432309 [TBL] [Abstract][Full Text] [Related]
75. Importance of immunogenicity testing for cost-effective management of psoriasis patients treated with adalimumab. Mota F; Neves E; Oliveira JC; Selores M; Torres T Acta Dermatovenerol Alp Pannonica Adriat; 2017 Jun; 26(2):33-35. PubMed ID: 28632883 [TBL] [Abstract][Full Text] [Related]
76. Serum retinol-binding protein 4 is associated with the presence and severity of coronary artery disease in patients with subclinical hypothyroidism. Sun HX; Ji HH; Chen XL; Wang L; Wang Y; Shen XY; Lu X; Gao W; Wang LS Aging (Albany NY); 2019 Jul; 11(13):4510-4520. PubMed ID: 31278889 [TBL] [Abstract][Full Text] [Related]
78. Effect of Adalimumab on Gene Expression Profiles of Psoriatic Skin and Blood. Chow M; Lai K; Ahn R; Gupta R; Arron S; Liao W J Drugs Dermatol; 2016 Aug; 15(8):988-94. PubMed ID: 27538000 [TBL] [Abstract][Full Text] [Related]
79. The Association between Serum Retinol-Binding Protein 4 Levels and Cardiovascular Events in Patients with Chronic Kidney Disease. Su Y; Huang Y; Jiang Y; Zhu M Lab Med; 2020 Sep; 51(5):491-497. PubMed ID: 31999339 [TBL] [Abstract][Full Text] [Related]
80. Retinol and vitamin A metabolites accumulate through RBP4 and STRA6 changes in a psoriasis murine model. Wang HM; Wu C; Jiang YY; Wang WM; Jin HZ Nutr Metab (Lond); 2020; 17():5. PubMed ID: 31956331 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]